Nav: Home

COPD symptoms common among smokers, even when undiagnosed

May 16, 2016

A new study in the New England Journal of Medicine finds that smokers, who wouldn't typically be diagnosed with chronic obstructive pulmonary disease, or COPD, are still showing symptoms consistent with the diagnosis.

According to the Centers for Disease Control and Prevention, COPD is the third-leading cause of death in the United States with tobacco smoke being a key factor in its cause.

COPD causes breathing-related problems and blockage of airflow in the body. Symptoms of the disease include shortness of breath, coughing, difficulty exercising and history of asthma. It's diagnosed using spirometry, a breathing test that checks how well your lungs can inhale and exhale.

Researchers looked at spirometry data and respiratory symptoms of more than 2,700 patients, including current or former smokers, as well as individuals who never smoked. They found that about half of current or former smokers experienced respiratory symptoms similar to COPD, as well as an increased risk for flare-ups in their symptoms, even though their lungs seemed to function normally according to the spirometry test results.

Meilan Han, M.D., one of the lead authors of the study, an associate professor of internal medicine at the University of Michigan, and the medical director of the U-M Women's Respiratory Health Program, explains more about the results.

What is the most important takeaway from the study?

Han: We found that a significant number of current and former smokers who don't meet the typical criteria for COPD (based on a breathing test)otherwise look and behave like patients who do carry a diagnosis of COPD.

Can you expand on that finding?

Han: Specifically, we found significant respiratory symptoms in half of the current or former smokers with technically "normal" breathing tests. We also found that these individuals needed to seek medical attention for breathing flare-ups with similar frequency as some patients who actually meet criteria for a diagnosis of COPD.

How do you think this study will benefit this patient group in the future?

Han: My hope is that it will generate more research on this group of patients, as clinically they have evidence of disease, but we have no name for the condition. At the University of Michigan, we will actually be leading a National Institutes of Health-sponsored trial to study use of a bronchodilator medication in this patient population to understand if this type of medication actually helps improve symptoms. This will be the first step towards providing some guidance for physicians on how to treat these patients.

Do you think this study points out that the definition of COPD should be adjusted?

Han: That's a great question. I think we do need a name for this condition so we can define these patients and develop treatments. However, it's still unclear whether these patients have "early" COPD, in that they will ultimately progress to airflow obstruction that we can detect on a breathing test. More information is still needed.

Why did you want to study this topic/specific patient base?

Han: Clinically, this is an important group of patients that we as physicians currently have no guidance on how to treat. A significant percentage of these symptomatic smokers with "normal" breathing tests had been given respiratory medications by their doctors to treat their symptoms, but this is a group of individuals that has never really been studied with those medications in clinical trials. Therefore physicians really have no evidence base to guide decision making.

Why should the general public care about this topic?

Han: Given how common smoking is, everyone likely knows someone who suffers the condition we describe here. As these patients may require medical treatment and in some cases even hospitalization, the impact of this condition is very real. This study is just the first step in trying to better identify these patients so we can develop targeted treatments.
-end-


University of Michigan Health System

Related Copd Articles:

COPD appears to cause more severe symptoms in women
Women who develop COPD report smoking fewer cigarettes than men; and yet, women experience greater breathing impairments, are subjected to more acute exacerbations of symptoms and report lower quality of life than men with the disease, according to research presented at ATS 2019.
African-Americans with COPD appear less likely to use pulmonary rehab
African-American patients with chronic obstructive pulmonary disease, or COPD, are less likely to participate in pulmonary rehabilitation programs than white patients, even when there are programs nearby.
COPD and type 2 diabetes
COPD and type 2 diabetes are two highly prevalent global health conditions associated with high mortality and morbidity.
Number of nonsmokers with COPD on the rise
The global burden of COPD is high, and prevalence of nonsmokers with COPD has been increasing.
Flu vaccination keeps COPD patients out of the hospital
A new study published in the January issue of CHEST® establishes that patients with chronic obstructive pulmonary disease (COPD) face heightened risks of death, critical illness, and hospitalization if they develop the flu and demonstrates the beneficial effects of influenza vaccination.
More Copd News and Copd Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...